Literature DB >> 25291031

Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells.

Shuso Takeda1, Eriko Ikeda2, Shengzhong Su3, Mari Harada2, Hiroyuki Okazaki4, Yasushi Yoshioka2, Hajime Nishimura2, Hiroyuki Ishii2, Kazuhiro Kakizoe2, Aya Taniguchi2, Miki Tokuyasu2, Taichi Himeno2, Kazuhito Watanabe5, Curtis J Omiecinski3, Hironori Aramaki6.   

Abstract

We recently reported that Δ(9)-tetrahydrocannabinol (Δ(9)-THC), a major cannabinoid component in Cannabis Sativa (marijuana), significantly stimulated the expression of fatty acid 2-hydroxylase (FA2H) in human breast cancer MDA-MB-231 cells. Peroxisome proliferator-activated receptor α (PPARα) was previously implicated in this induction. However, the mechanisms mediating this induction have not been elucidated in detail. We performed a DNA microarray analysis of Δ(9)-THC-treated samples and showed the selective up-regulation of the PPARα isoform coupled with the induction of FA2H over the other isoforms (β and γ). Δ(9)-THC itself had no binding/activation potential to/on PPARα, and palmitic acid (PA), a PPARα ligand, exhibited no stimulatory effects on FA2H in MDA-MB-231 cells; thus, we hypothesized that the levels of PPARα induced were involved in the Δ(9)-THC-mediated increase in FA2H. In support of this hypothesis, we herein demonstrated that; (i) Δ(9)-THC activated the basal transcriptional activity of PPARα in a concentration-dependent manner, (ii) the concomitant up-regulation of PPARα/FA2H was caused by Δ(9)-THC, (iii) PA could activate PPARα after the PPARα expression plasmid was introduced, and (iv) the Δ(9)-THC-induced up-regulation of FA2H was further stimulated by the co-treatment with L-663,536 (a known PPARα inducer). Taken together, these results support the concept that the induced levels of PPARα may be involved in the Δ(9)-THC up-regulation of FA2H in MDA-MB-231 cells.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fatty acid 2-hydroxylase; Human breast cancer cells; MDA-MB-231 cells; Peroxisome proliferator-activated receptorα; Δ(9)-tetrahydrocannabinol

Mesh:

Substances:

Year:  2014        PMID: 25291031      PMCID: PMC4258431          DOI: 10.1016/j.tox.2014.09.011

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  40 in total

1.  Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.

Authors:  P Delerive; K De Bosscher; S Besnard; W Vanden Berghe; J M Peters; F J Gonzalez; J C Fruchart; A Tedgui; G Haegeman; B Staels
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

2.  Forensic chemical study on marihuana. I. A detection method of the principal constituents by thin-layer and gas chromatographies.

Authors:  H Aramaki; N Tomiyasu; H Yoshimura; H Tsukamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1968-05       Impact factor: 1.645

3.  Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions.

Authors:  I Avis; S H Hong; A Martinez; T Moody; Y H Choi; J Trepel; R Das; M Jett; J L Mulshine
Journal:  FASEB J       Date:  2001-07-09       Impact factor: 5.191

4.  Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.

Authors:  Z Dong; C Huang; R E Brown; W Y Ma
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

5.  Cannabinoids and PPARalpha signalling.

Authors:  Y Sun; S P H Alexander; D A Kendall; A J Bennett
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

6.  Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Authors:  Pei-Li Yao; Jose L Morales; Bokai Zhu; Boo-Hyon Kang; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cancer Ther       Date:  2014-01-24       Impact factor: 6.261

7.  Δ9-Tetrahydrocannabinol targeting estrogen receptor signaling: the possible mechanism of action coupled with endocrine disruption.

Authors:  Shuso Takeda
Journal:  Biol Pharm Bull       Date:  2014       Impact factor: 2.233

8.  Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors:  E Kopp; S Ghosh
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

9.  Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia.

Authors:  Simon Edvardson; Hiroko Hama; Avraham Shaag; John Moshe Gomori; Itai Berger; Dov Soffer; Stanley H Korman; Ilana Taustein; Ann Saada; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2008-11       Impact factor: 11.025

10.  Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin.

Authors:  Serge Hardy; Wissal El-Assaad; Ewa Przybytkowski; Erik Joly; Marc Prentki; Yves Langelier
Journal:  J Biol Chem       Date:  2003-06-12       Impact factor: 5.157

View more
  11 in total

1.  Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.

Authors:  Mary K Swinton; Aliyah Carson; Francesca Telese; Ana B Sanchez; Benchawanna Soontornniyomkij; Leila Rad; Isabella Batki; Brandi Quintanilla; Josué Pérez-Santiago; Cristian L Achim; Scott Letendre; Ronald J Ellis; Igor Grant; Anne N Murphy; Jerel Adam Fields
Journal:  Neurobiol Dis       Date:  2019-06-22       Impact factor: 5.996

2.  Neuromolecular Mechanisms of Cannabis Action.

Authors:  Yousra Adel; Stephen P H Alexander
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness.

Authors:  Shuso Takeda; Taichi Himeno; Kazuhiro Kakizoe; Hiroyuki Okazaki; Tomoko Okada; Kazuhito Watanabe; Hironori Aramaki
Journal:  J Nat Med       Date:  2016-08-16       Impact factor: 2.343

Review 4.  Molecular Targets of the Phytocannabinoids: A Complex Picture.

Authors:  Paula Morales; Dow P Hurst; Patricia H Reggio
Journal:  Prog Chem Org Nat Prod       Date:  2017

Review 5.  Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.

Authors:  Rowan Saloner; Jerel Adam Fields; Maria Cecilia Garibaldi Marcondes; Jennifer E Iudicello; Sofie von Känel; Mariana Cherner; Scott L Letendre; Marcus Kaul; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

6.  Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol.

Authors:  Zacharias Pandelides; Neelakanteswar Aluru; Cammi Thornton; Haley E Watts; Kristine L Willett
Journal:  Toxicol Sci       Date:  2021-07-16       Impact factor: 4.849

7.  DHA induces apoptosis of human malignant breast cancer tissues by the TLR-4/PPAR-α pathways.

Authors:  Lijing Geng; Wei Zhou; Bing Liu; Xinyun Wang; Bo Chen
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

Review 8.  An update on PPAR activation by cannabinoids.

Authors:  Saoirse Elizabeth O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-05-19       Impact factor: 8.739

Review 9.  The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.

Authors:  Mohammed I Khan; Anna A Sobocińska; Anna M Czarnecka; Magdalena Król; Bruno Botta; Cezary Szczylik
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 10.  A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC.

Authors:  Seok Hee Kim; Jin Won Yang; Kyung Han Kim; Jong Uk Kim; Tae Han Yook
Journal:  J Pharmacopuncture       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.